Advertisement

Fever of Unknown Origin (FUO) – A Call for New Research Standards and Updated Clinical Management

      Abstract

      Prolonged fever of 38.3°C or higher for at least 3 weeks’ duration has been termed fever of unknown origin if unexplained after preliminary investigations. Initially codified in 1961, classification with subgroups was revised in 1991. Additional changes to the definition were proposed in 1997, recommending a set of standardized initial investigations. Advances in diagnosis and management and diagnostic testing over the last 3 decades have prompted a needed update to the definition and approaches. While a 3-week fever duration remains part of the criteria, a lower temperature threshold of 38°C and revised minimum testing criteria will assist clinicians and their patients, setting a solid foundation for future research.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Petersdorf RG
        • Beeson PB
        Fever of unexplained origin: report on 100 cases.
        Medicine (Baltimore). 1961; 40: 1-30
        • Durack DT
        • Street AC
        Fever of unknown origin–reexamined and redefined.
        Curr Clin Top Infect Dis. 1991; 11: 35-51
        • Alt HL
        • Barker MH
        Fever of unknown origin.
        JAMA. 1930; 94: 1457-1461
        • de Kleijn EM
        • Vandenbroucke JP
        • van der Meer JW
        Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group.
        Medicine (Baltimore). 1997; 76: 392-400
        • Kintner AR
        • Rowntree LG
        Long-continued, low-grade, idiopathic fever. Analysis of 100 cases.
        JAMA. 1934; 102: 889
        • Hamman L
        • Wainwright CW
        Diagnosis of obscure fever. I. The diagnosis of unexplained, long-continued, low-grade fever.
        Bull Johns Hopkins Hosp. 1936; 58: 109-133
        • Hamman L
        • Wainwright CW
        Diagnosis of obscure fever. II. The diagnosis of unexplained high fever.
        Bull Johns Hopkins Hosp. 1936; 58: 307
        • Bottiger LE
        Fever of unknown origin. With some remarks of the normal temperature in man.
        Acta Med Scand. 1953; 147: 133
        • Petersdorf RG
        • Larson E
        FUO revisited.
        Trans Am Clin Climatol Assoc. 1983; 94: 44-54
        • Bleeker-Rovers CP
        • Vos FJ
        • de Kleijn EM
        • et al.
        A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.
        Medicine (Baltimore). 2007; 86: 26-38
        • Protsiv M
        • Ley C
        • Lankester J
        • Hastie T
        • Parsonnet J
        Decreasing human body temperature in the United States since the industrial revolution.
        Elife. 2020; 9: e49555
        • Affronti M
        • Mansueto P
        • Soresi M
        • et al.
        Low-grade fever: how to distinguish organic from non-organic forms.
        Int J Clin Pract. 2010; 64: 316-321
        • Knockaert DC
        • Dujardin KS
        • Bobbaers HJ
        Long-term follow-up of patients with undiagnosed fever of unknown origin.
        Arch Intern Med. 1996; 156: 618-620
        • Vanderschueren S
        • Knockaert D
        • Adriaenssens T
        • et al.
        From prolonged febrile illness to fever of unknown origin: the challenge continues.
        Arch Intern Med. 2003; 163: 1033-1041
        • Zenone T
        Fever of unknown origin in adults: evaluation of 144 cases in a nonuniversity hospital.
        Scand J Infect Dis. 2006; 38: 632-638
        • Mulders-Manders CM
        • Pietersz G
        • Simon A
        • et al.
        Referral of patients with fever of unknown origin to an expertise center has high diagnostic and therapeutic value.
        QJM. 2017; 110: 793-801
        • Geneva II
        • Cuzzo B
        • Fazili T
        • et al.
        Normal body temperature: a systematic review.
        Open Forum Infect Dis. 2019; 6: ofz032
        • Mulders-Manders C
        • Simon A
        • Bleeker-Rovers C
        Fever of unknown origin.
        Clin Med (Lond). 2015; 15: 280-284
        • Konecny P
        • Davidson RN
        Pyrexia of unknown origin in the 1990s: time to redefine.
        Br J Hosp Med. 1996; 56: 21-24
        • Whitehead TC
        • Davidson RN
        Pyrexia of unknown origin: changing epidemiology.
        Curr Opin Infect Dis. 1997; 10: 134-138
        • DiNubile MJ
        Acute fevers of unknown origin. A plea for restraint.
        Arch Intern Med. 1993; 153: 2525-2526
        • Horowitz HW
        Fever of unknown origin or fever of too many origins?.
        N Engl J Med. 2013; 368: 197-199
        • Fusco FM
        • Pisapia R
        • Nardiello S
        • et al.
        Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review.
        BMC Infect Dis. 2019; 19: 653
        • Wright WF
        • Auwaerter P
        • Dibble EH
        • Rowe SP
        • Mackowiak PA
        Imaging a fever-redefining the role of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography in fever of unknown origin investigations.
        Clin Infect Dis. 2021; 72: 1279-1286
        • Heinz WJ
        • Buchheidt D
        • Christopeit M
        • et al.
        Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
        Ann Hematol. 2017; 96: 1775-1792
        • Freifeld AG
        • Bow EJ
        • Sepkowitz KA
        • et al.
        Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America.
        Clin Infect Dis. 2011; 52: e56-e93
        • Bouza E
        • Loeches B
        • Munoz P
        Fever of unknown origin in solid organ transplant recipients.
        Infect Dis Clin North Am. 2007; 21: 1033-1054
        • Wright WF
        • Auwaerter PG
        Fever and fever of unknown origin: review, recent advances, and lingering dogma.
        Open Forum Infect Dis. 2020; 7: ofaa132
        • Chai-Chien H
        • Sandford BA
        The Delphi technique: making sense of consensus.
        Pract Assess Res Eval. 2007; 12: 1-9
        • Wright WF
        • Simner PJ
        • Carroll KC
        • Auwaerter PG
        Progress report: next-generation sequencing (NGS), multiplex polymerase chain reaction (PCR), and broad-range molecular assays as diagnostic tools for fever of unknown origin (FUO) investigations in adults.
        Clin Infect Dis. 2021; ([online ahead of print]) (Feb 19ciab155)
        • Kimura M
        • Sakamoto M
        • Adachi T
        • et al.
        Diagnosis of febrile illnesses in returned travelers using PC software GIDEON.
        Travel Med Infect Dis. 2005; 3: 157-160
        • Bottieau E
        • Moreira J
        • Clerinx J
        • et al.
        Evaluation of the GIDEON expert computer program for the diagnosis of imported febrile illnesses.
        Med Decis Making. 2008; 28: 435-442
        • Mourad O
        • Palda V
        • Detsky AS
        A comprehensive evidence-based approach to fever of unknown origin.
        Arch Intern Med. 2003; 163: 545-551